Glooko®
Glooko puts all of your glucose readings, insulin data and fitness tracking stats together in one app. Stay on track with personalized tips, simple reports, and share with your healthcare team.
LEARN MORE ↗
Insulin Pump Integration
COMING SOON!
Good news, Eversense 365 will integrate with the twiistTM automated insulin delivery system in addition to the apps it is already compatible with.
Coming Soon: Connected Pumps
Insulin pump integration
Eversense will soon be the only one year CGM cleared for use in automated insulin delivery (AID) systems, starting with the twiistTM AID system.
Lifestyle Devices
Apple Health™
Within the Eversense 365 App, the Share My Data feature allows you to share your Eversense data with Apple Health. Tap the Apple Health application and turn on Share Data. You may need to also allow sharing via the health application.
LEARN MORE ↗
Apple Watch®
You can view a snapshot of your CGM data on your Apple Watch. The wearable is a secondary display of Eversense data and should not be used in place of the primary CGM app display.
LEARN MORE ↗Your Health App Ecosystem: Beyond the Pump
Tidepool
Tidepool is a nonprofit organization providing software that makes diabetes data - pump, meter, CGM - more accessible, meaningful, and actionable within the Tidepool Data Platform.
LEARN MORE ↗
SNAQ
SNAQ is an award winning app that supports people living with diabetes to take the guesswork out of meals. SNAQ helps to count the carbs, protein and fat content in meals by snapping a photo.
LEARN MORE ↗
Sweetspot
SweetSpot is a remote diabetes management platform that supports all major CGM and insulin delivery devices to provide physicians with a single view of their data in one place.
LEARN MORE ↗
Device compatibility
Eversense 365 is compatible with many major mobile devices, operating systems, and software platforms. For a list of compatible devices and services, click here.
Frequently asked questions
CGM integration with the twiistTM insulin pump allows for continuous glucose data to be sent to your insulin pump. This enables the pump to make automatic adjustments to insulin delivery based on real-time glucose readings and trends, helping to maintain glucose levels within a target range and reduce the need for manual intervention.
Eversense 365 is an interoperable Continuous Glucose Monitoring (iCGM) system, meaning it is designed to communicate with compatible medical devices, including the twiistTM insulin pump and automated insulin delivery (AID) systems. For specific compatibility information with your insulin pump, it is best to consult with your healthcare provider or refer to the latest compatibility list provided by Eversense.
An automated insulin delivery (AID) system is a technology that connects a continuous glucose monitor (CGM) with an insulin pump. It uses algorithms to automatically adjust insulin delivery based on real-time glucose readings, predicted glucose trends, and user-defined parameters, aiming to keep glucose levels within a healthy range with less user input.
Before switching to Eversense 365, you should discuss your current diabetes management plan, your specific health needs, and the compatibility of Eversense 365 with your existing or planned insulin pump or AID system. Your healthcare provider can help determine if this system is appropriate for you and guide you through the transition.
Yes, Eversense 365 can connect with a number of health apps including Apple Health, Glooko, Tidepool, SNAQ and SweetSpot.
Need support?
Call
Monday - Sunday 8am-12am
EST 1-844-736-7348 (844-SENSE4U)
Send us a question and we will get
back to you within 3 business days.
Monday-Saturday
eversense.us@ascensia.com
The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For important safety information, see bit.ly/eversensesafety
Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.
PP-SENS-365-GBL-0229